Related Experiment Video
Updated: Jun 20, 2026
06:26
Analyzing the Permeability of the Blood-Brain Barrier by Microbial Traversal through Microvascular Endothelial Cells
Published on: February 14, 2020
Methylglyoxal: possible link between hyperglycaemia and immune suppression?
Claire L Price1, Stella C Knight
1Antigen Presentation Research Group, Imperial College London Faculty of Medicine, Level 7W, NWLH campus, Watford Road, Harrow, Middlesex, HA1 3UJ, UK.
Trends in Endocrinology and Metabolism: TEM
|August 28, 2009
Summary
Methylglyoxal (MG), a byproduct of high blood sugar in diabetes, may suppress the immune system. This review explores how MG contributes to diabetic complications and infections.
Area of Science:
- Endocrinology
- Immunology
- Metabolic Research
Background:
- Diabetes mellitus is characterized by hyperglycemia, leading to increased methylglyoxal (MG) production.
- MG forms advanced glycation end-products (AGEs) that contribute to diabetic complications via the receptor for AGEs (RAGE).
- Diabetic patients exhibit reduced immune resistance to infections, with underlying causes often unclear.
Purpose of the Study:
- To review current evidence on immune suppression in diabetes.
- To investigate the impact of methylglyoxal (MG) on immune system components.
- To propose MG as a potential link between hyperglycemia and immune dysfunction in diabetes.
Main Methods:
- Literature review of recent studies on diabetes, hyperglycemia, methylglyoxal, and immune function.
- Analysis of pathways linking MG, AGEs, RAGE, and cellular damage.
- Discussion of MG's effects on various immune system components.
Main Results:
- Hyperglycemia elevates methylglyoxal (MG) levels, promoting AGE formation.
- AGEs and RAGE signaling contribute to vascular and neuronal injury in diabetes.
- Evidence suggests MG may directly impair immune cell function, explaining reduced infection resistance.
Conclusions:
- Methylglyoxal (MG) is a key mediator linking hyperglycemia to cellular damage and diabetic complications.
- MG's detrimental effects on the immune system present a plausible explanation for increased infection susceptibility in diabetes.
- Targeting MG or its pathways may offer novel therapeutic strategies for managing diabetic complications and immune dysfunction.
Related Concept Videos
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:19Overview of Carbohydrate Metabolism
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...